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Cardiovascular disease (CVD) is an ever-growing cause of mortality and has been 
coupled with a rise in sedentary behavior. A vast majority of people spend their time 
physically inactive with the occasional bout of acute exercise. Generally, acute exercise is 
able to improve postprandial lipemia (PPL), a risk factor for CVD.  However, research is 
beginning to suggest that sedentary behavior might abolish the metabolic benefits 
normally seen from exercise. This study set out to elucidate the impact of an acute bout 
of exercise on PPL after four days of prolonged sitting (~13.5 h/day). Subjects 
participated in a counterbalanced, crossover study in which they completed two trials: 
prolonged sitting without exercise (SIT) and prolonged sitting with a one-hour bout of 
treadmill exercise (SIT+EX). Following each trial, plasma triglycerides and glucose were 
obtained and substrate oxidation via indirect calorimetry was collected to be analyzed for 
possible improvements caused by exercise. No differences (p>0.05) were found in 
triglyceride or glucose response during the high fat tolerance test, evidenced by 
triglyceride or glucose AUCt or AUCi, or fat oxidation as measured by indirect 
 vi 
calorimetry between trials. While the triglyceride temporal response was similar to 
expectation with a rise to peak around hour 3-4 postprandial, a noticeably flatter and 
more prolonged response was seen in the glucose temporal response. This lack of 
difference between trials comes with similar activity except for the one-hour bout of 
exercise. The results from this study suggest that prolonged sitting imposes some sort of 
resistance to the normal improvement in PPL and fat oxidation after acute exercise. This 
suggests that physical inactivity (e.g. prolonged sitting) creates a condition whereby 
people are resistant to the normal metabolic improvements in fat metabolism that are 
derived from a bout of acute exercise.  
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Chapter 1: General Introduction 
1.1 BACKGROUND 
The modernization of society has led to vast technological advancements that 
have improved the quality of life and the longevity of the population across the world. 
However, with a modernizing society come serious problems in that more people are 
spending their time sedentary. Couple this with improvements in agriculture and 
sustainability and people are spending more time sitting in a fed state. Along with this 
rise in sedentary behavior has come an increase in the mortality rate as caused by 
cardiovascular disease (National Center for Health Statistics, 2016). This phenomenon 
may be driven by the rise in atherosclerosis driven by postprandial sedentary behavior. 
As early as 1979, atherosclerosis was described as a “postprandial phenomenon” 
(Zilversmit, 1979). Rising plasma triglyceride concentration after a meal (Dash, Xiao, 
Morgantini, & Lewis, 2015; Goldberg, 2009; Hussain, 2000) may be driving the 
pathogenesis of atherosclerosis. 
Exercise has been a well-documented mechanism to attenuate the rise in PPL 
(Beidleman et al., 2008; Herd, Kiens, Boobis, & Hardman, 2001; Malkova et al., 2000; 
Zhang, Thomas, & Ball, 1998) However, despite well-established (Garber et al., 2011) 
and newly formed recommendations (Ekelund, Steene-Johannessen, & Brown, 2016) for 
exercise, the exercise performed may not be enough to overcome the detrimental effects 
of sedentary time. New evidence is beginning to suggest that prolonged sitting and 
sedentary time may reverse or impair the positive effects generally caused by exercise 
(Duvivier et al., 2013; Kim, Park, Chou, Trombold, & Coyle, 2016). In order to 
counteract this so-called exercise resistance, higher levels of physical activity throughout 
the day may be needed. In fact, many studies are now pointing to the idea that breaking 
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up sedentary time, independent of total moderate to vigorous physical activity, may be 
able to attenuate PPL as compared to their sedentary counterparts (Duvivier et al., 2013; 
Healy et al., 2008; Peddie et al., 2013). It is thus imperative to determine if prolonged 
sitting does limit the effectiveness of an acute bout of exercise to reverse impaired PPL, 
as a resistance may demonstrate that acute exercise when engaging in otherwise 
sedentary behavior has little effect on improving PPL (Kim et al., 2016). The goal of this 
study is to quantify how PPL responds to prolonged sitting with and without an acute 
bout of moderate intensity exercise. 
 
1.2 RESEARCH PURPOSE AND HYPOTHESIS 
The goal of this study is to determine the impact of a single bout of acute exercise 
on plasma triglycerides and glucose, as well as fat oxidation after an acute bout of 
prolonged sitting. Two groups will undergo the prolonged sitting, but only one will 
perform the exercise. The specific hypothesis is as follows:  
1. A single bout of 1-hour of running at 65% VO2max after prolonged sitting (>14 
h/d) will not produce significantly different postprandial triglyceride 
responses as compared to the control of just sitting.  
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Chapter 2: Review of Literature 
2.2 INTRODUCTION 
Ensuring individuals live long, healthy lives is a central tenet of modern medicine. 
However, despite the astounding technological advances that the world has witnessed 
over the past century, medical treatment is not a fully effective solution for many 
disorders and needs to be coupled with active prevention. Over the past few decades, 
heart disease has constantly been the number one cause of mortality in the United States 
constituting nearly one-quarter of all deaths (National Center for Health Statistics, 2016). 
Between 1980 and 2014, heart disease saw a reduced contribution to mortality and saw 
all-cause cancer narrow the margin leaving the two as equals in terms of contribution to 
mortality (National Center for Health Statistics, 2016). However, it appears that heart 
disease is still a serious problem as it outnumbers all other causes of death by more than 
four-to-one (National Center for Health Statistics, 2016). 
As heart disease acts as a subcategory of general cardiovascular disease, the risk 
factors that contribute to heart disease should also contribute to cardiovascular disease. 
Of all the factors that contribute to cardiovascular disease, atherosclerosis is perhaps the 
most important (Libby, 2002). Atherosclerosis has numerous sources that contribute to its 
development, one of which is the presence of abnormal blood lipids (Mozaffarian et al., 
2015; Nordestgaard, Benn, Schnohr, & Tybjaerg-Hansen, 2007; Zilversmit, 1979). 
However, it seems as though some parties may be quick to suggest pharmaceutical 
intervention (Bansal et al., 2007) when it seems that inactivity may be an easily 
correctable factor that can reduce the risk of atherosclerosis (Laufs et al., 2005; 
Mozaffarian et al., 2015). Modern society presents all the factors for a perfect 
environment leading to atherosclerosis including modern technology allowing for a 
sedentary lifestyle and an abundance of food that influence the body’s lipids and 
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endothelial function. Without proper intervention, such as adequate exercise or physical 
activity, cardiovascular disease will continue to be a serious problem in modern 
medicine. 
 
2.2 HYPERTRIGLYCERIDEMIA AND ATHEROSCLEROSIS 
Blood lipids can be measured during either the fasting or postprandial states, both 
of which offer insight into the triglyceride connection to cardiovascular disease. Several 
groups have found relationships between fasting triglyceride levels and cardiovascular 
disease (Assmann, Schulte, & von Eckardstein, 1996; Jeppesen, Hein, Suadicani, & 
Gyntelberg, 1998; Manninen et al., 1992). High fasting triglyceride levels may be 
indicative of the body’s inability to clear triglycerides and leave them in circulation, 
which may cause downstream problems to be discussed later. However, it has been 
suggested that postprandial triglyceride levels are more strongly related to cardiovascular 
events than fasting triglyceride levels even when considering other factors (Bansal et al., 
2007; Nordestgaard et al., 2007). How elevated triglycerides occur and how they 
influence the formation of atherosclerosis is a multi-faceted explanation that includes 
both the sources and the physiological mechanisms attenuating clearance. 
 
2.2.1 Sources of Triglyceride 
Triglyceride can be derived from two different sources: exogenous and 
endogenous. Exogenous triglyceride is derived from dietary sources while endogenous 
triglyceride is synthesized within the liver (Goldberg, 2009). Both sources of triglyceride 
are composed of generally the same subunits composed of triglyceride, phospholipid, 
cholesterol, and cholesteryl ester in varying concentrations (Nichols, 1969). The 
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difference between exogenous and endogenous sources of triglyceride lies in how the 
lipid is delivered. In the case of exogenous sources, triglyceride is delivered 
predominantly via chylomicrons, while endogenous sources are delivered via very low-
density lipoproteins (VLDLs) (Goldberg, 2009; Nichols, 1969). 
As mentioned, chylomicrons are derived from dietary triglyceride intake and 
begin their life in the intestine as apolipoprotein B48 which is synthesized into and 
secreted as chylomicron. This assembly is not a constant process, however, and it has 
been suggested that it is only induced in the postprandial state. In addition, it appears that 
chylomicron production changes depending on the type of lipid consumed with saturated 
fat producing the greatest response and polyunsaturated fat producing the least response. 
These chylomicrons then serve to attach lipids that have been reassembled from contents 
hydrolyzed and absorbed in and from the lumen (Dash et al., 2015; Hussain, 2000). 
Chylomicrons are then secreted into the lymphatic system by the small intestine to begin 
delivery of lipids to the central circulation (Goldberg, 2009). This highly regulated 
process is important to ensure adequate triglyceride clearance. Approximately 95% of the 
100-150 g/day of triglycerides that adults consume is handled by chylomicrons of various 
sizes and compositions (Dash et al., 2015; Hussain, 2000). Given that chylomicrons are 
generally only synthesized and secreted in the postprandial state, fasting levels of 
chylomicron triglycerides should be lower. However, in certain diseases that present 
hypertriglyceridemia or hyperlipidemia such as diabetes, hyperchylomicronemia can 
occur in the fasted state due to increased VLDL levels and saturation of lipoprotein lipase 
(LPL), which will be discussed later (Dash et al., 2015; Goldberg, 2009; Zilversmit, 
1979). 
Derived in the liver, VLDLs are the major delivery method of triglycerides in the 
fasted state. While chylomicrons are dependent on apolipoprotein B48, VLDLs are 
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dependent on apolipoprotein B100 (Ginsberg, Zhang, & Hernandez-Ono, 2005; Hussain, 
2000). The formation of VLDL triglycerides is a substrate driven process reliant upon the 
concentration of hepatic free fatty acids (FFAs) (Nielsen & Karpe, 2012). Triglycerides 
attached to VLDL may also be of a carbohydrate origin that have been converted to 
triglyceride via de novo lipogenesis. This source of triglyceride may not be appreciable 
with dietary changes, however, unless the addition of dietary carbohydrate greatly 
exceeds total energy expenditure (Hellerstein, 1999; Nichols, 1969). Unlike 
chylomicrons, VLDL is constantly being produced to provide sources of triglycerides to 
different bodily tissues (Hussain, 2000). VLDL production is also influenced by certain 
disease states. Diabetes, particularly insulin resistant diabetes, leads to an increased 
secretion of VLDL into circulation. This increase in VLDL adds to the 
hypertriglyceridemia and hyperlipidemia presented via the increase in chylomicron 
circulation (Ginsberg et al., 2005; Lewis & Steiner, 1996; Nielsen & Karpe, 2012). 
Uptake and metabolism of chylomicrons and VLDL are regulated by a similar 
mechanism in LPL, as mentioned previously. LPL is an enzyme located on the luminal 
side of vascular endothelial cells in adipose, skeletal muscle, and myocardial tissue (Dash 
et al., 2015; Wang & Eckel, 2009). Metabolism of both chylomicrons and VLDLs are 
closely regulated by the ratios of apolipoproteins CII and CIII that have been acquired 
after these carriers have been circulated in the lymph and blood (Dash et al., 2015; 
Ginsberg et al., 2005). LPL subsequently hydrolyzes the triglyceride attached to 
chylomicron and VLDL sources to allow for uptake of fatty acid into adjacent cells. 
Aside from fatty acids, other remnants are produced by the hydrolysis process, namely 
low-density lipoproteins (LDLs) as an end product (Ginsberg et al., 2005). VLDLs may 
also undergo structural changes in the blood as lipid transfer proteins and hepatic lipase 
increase the production of LDL (Goldberg, 2009). This production of LDL and other 
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remnants are thought to be the major factors leading to the pathogenesis of 
atherosclerosis (Zilversmit, 1979). 
 
2.2.2 Mechanisms of Hypertriglyceridemia and their Link to Atherosclerosis 
As previously established, a strong association between hypertriglyceridemia and 
cardiovascular disease has been recognized (Assmann et al., 1996; Jeppesen et al., 1998; 
Manninen et al., 1992). Despite debate over the cause of atherosclerosis, the most 
common explanation for the onset of atherosclerotic formation begins with an increased 
accumulation of lipoprotein behind the endothelial wall of the vasculature (Lusis, 2000; 
Navab et al., 1995; Williams & Tabas, 2005). These molecules are then rapidly trapped in 
the subendothelial space through interactions with apolipoprotein B and matrix 
proteoglycans (Lusis, 2000; Navab et al., 1995; Tabas, Williams, & Boren, 2007). Once 
trapped, LDL undergoes modification via oxidation, lipolysis, proteolysis, and 
aggregation. All of these changes lead to the formation of foam cells via macrophage 
infiltration/conversion and to inflammation of the surrounding tissue (Lusis, 2000; Tabas 
et al., 2007). This damaged tissue and subsequent lipid/cholesterol infiltration eventually 
heals and develops a fibrous cap consisting of smooth muscle cells. The underlying tissue 
then forms a necrotic core and the exterior may begin to calcify. However, this area is 
suspect to further injury, especially if the fibrous cap that forms is particularly thin. In 
this case, further growth of the lesion or breaking off of the cap and potential release of 
the interior contents of the lesion can lead to thrombosis (Lusis, 2000; Tabas, 2004). As 
soon as thrombosis occurs, the risk of cardiovascular events, such as stroke or myocardial 
infarction, greatly increases. 
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Though the primary factor for the development of atherosclerotic lesions seems to 
be LDL, there are other substances that may add to the formation of atherosclerosis. The 
two molecules, chylomicrons and VLDL, which contribute to LDL formation via LPL 
hydrolysis and blood conformational changes are not necessarily atherosclerotic on their 
own. Rather, the remnant products of hydrolysis and lipolysis of chylomicrons and 
VLDL contribute directly to the accumulation of lipoproteins in the subendothelial space 
(Tabas, 2004). As the concentration of chylomicrons increases postprandially while 
VLDL continues to be released, as its production is controlled by liver concentrations of 
FFAs, the amount of circulating triglyceride and cholesterol is elevated to significant 
levels (Zilversmit, 1979). As chylomicrons and VLDLs both utilize LPL (Dash et al., 
2015; Wang & Eckel, 2009) as an uptake mechanism, postprandial saturation of LPL can 
occur as the two molecules compete for binding sites. Therefore, this increase in 
circulating cholesterol/triglycerides and concomitant saturation of LPL allows for the 
opportunity for chylomicron and VLDL byproducts to build up in the subendothelial 
space. In addition to this formation of lesions, increased concentrations of VLDL cause 
corresponding decreases in high density lipoprotein (HDL) concentrations (Ginsberg et 
al., 2005). This is problematic as HDL is generally believed to have protective effects 
against atherosclerosis (Ginsberg et al., 2005; Lusis, 2000; Navab et al., 1995; Williams 
& Tabas, 2005). 
 
2.3 EXERCISE AND HYPERTRIGLYCERIDEMIA 
Exercise is commonly recognized to decrease the risk of a variety of systemic 
diseases and metabolic disorders. Among those that exhibit a reduced prevalence are 
cardiovascular disease, insulin resistant diabetes mellitus, and select cancers (Beidleman 
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et al., 2008). Given the possible therapeutic nature that exercise provides for a variety of 
diseases, it is necessary to explore the cause and effect nature of exercise. In particular, 
exercise can have an impact on postprandial hyperlipidemia by affecting circulating 
triglyceride levels (Beidleman et al., 2008; Herd et al., 2001; Malkova et al., 2000; Zhang 
et al., 1998). By lowering the postprandial triglyceride levels, it may be possible to 
reduce the risk of atherosclerosis through previously discussed mechanisms, thus making 
exercise a viable alternative to pharmaceutical treatment. 
 
2.3.1 Factors of Exercise Attenuating Postprandial Lipemia (PPL) 
The current school of thought believes that an acute bout of aerobic exercise is 
able to attenuate PPL. This recommendation comes with a wide range of intensities and 
times that exhibit change, ranging in intensity from 25-90% of maximal oxygen uptake 
(VO2max) and in total time from 30-120 minutes (Beidleman et al., 2008; Gill & 
Hardman, 2000; Herd et al., 2001; Kim, Park, Trombold, & Coyle, 2014; Malkova et al., 
2000; Miyashita, Burns, & Stensel, 2009; Trombold, Christmas, Machin, Kim, & Coyle, 
2013; Zhang et al., 1998). On the other hand, there seems to be little in the way of 
literature as it relates to chronic training status or chronic exercise regimens and their 
relation to PPL. A study conducted by Holloszy et al. (1964) investigated the effects of a 
6-month endurance training program, but PPL was not investigated in this study, only 
fasting lipids were looked at. Those studies that did investigate the relationship between 
these factors generally had subjects withhold from exercise performance to determine at 
what point the transient effect of exercise on blood triglyceride is abolished (Hardman, 
Lawrence, & Herd, 1998; Herd et al., 2000). Several factors have been proposed to affect 
the reduction in PPL via exercise: timing of exercise in relation to a high fat meal 
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(Beidleman et al., 2008; Zhang et al., 1998), especially previous bouts of exercise (Herd 
et al., 2000), intensity of exercise and whether exercise is continuous or intermittent (Kim 
et al., 2014; Miyashita et al., 2009; Trombold et al., 2013), and diet and exercise energy 
balance (Gill & Hardman, 2000; Kim et al., 2016). 
 
2.3.2 Timing of Exercise on PPL 
Understanding the point at which exercise begins to have an effect on 
postprandial triglyceride levels and the point at which that effect disappears is crucial in 
maintaining ideal triglyceride levels, especially if a diet is high in triglyceride. Zhang et 
al. (1998) looked at the postprandial responses in a group of trained men during a control 
without exercise, exercise after a high fat meal, exercise 1-hour prior to the high fat meal, 
and exercise 12-hours prior to the high fat meal. While the control had the highest 
triglyceride area under the curve (AUC), exercising after a meal had negligible effects on 
triglyceride AUC. However, both conditions with exercise prior to the meal demonstrated 
substantial reductions in triglyceride AUC, with 12-hours pre-meal producing similar 
reductions to 1-hour pre-meal (Zhang et al., 1998). This prior exercise phenomenon was 
also observed by Herd et al. (2001) when subjects exercised the afternoon prior to an oral 
fat-tolerance test. Later research was able to further validate that exercise prior to a high 
fat meal attenuates the postprandial triglyceride response generally seen. Silvestre et al. 
(2008) looked at exercise 4-hours and 16-hours prior to the meal and their relation to a 
non-exercising control condition. As previously demonstrated, both conditions 
significantly reduced triglyceride AUC as compared to the control, but were not 
significantly different from each other. This prior exercise effect may extend farther than 
12-16 hours before the test meal. It has been suggested that postprandial triglyceride 
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response may be attenuated for at least 42-hours post-exercise and return to baseline by 
60-hours post-exercise, regardless of prior training status (Herd et al., 2000; Kantor, 
Cullinane, Herbert, & Thompson, 1984) Other groups have suggested that this transient 
effect may only last 24-40 hours before disappearing (Maraki & Sidossis, 2013). The 
most common explanation for this delayed effect is an upregulation of LPL, which allows 
for greater clearance of blood triglycerides due to an increase in binding sites along the 
luminal wall (Herd et al., 2001; Herd et al., 2000; Kantor et al., 1984; Maraki & Sidossis, 
2013). However, LPL levels have been noted to return to baseline 24-hours post-exercise 
(Seip & Semenkovich, 1998) or they may have not increased as a result of exercise at all 
(Maraki & Sidossis, 2013). Thus, the cause of exercise’s effect on PPL is only partially 
elucidated through an LPL mechanism. 
 
2.3.3 Exercise Intensity and Continuity 
The continued popularity of interval style training (particularly high-intensity 
interval training [HIIT]) presents an important question regarding intensity and 
intermittency and their relationships with PPL. Trombold et al. (2013) found that 
incremental AUC for triglycerides was significantly lower for high-intensity interval style 
exercise than both isoenergetic moderate intensity continuous exercise or a non-exercise 
control. This effect was attributed to a higher rate of glycogen utilization during exercise, 
which subsequently increased the rate of postprandial fat oxidation, lowering 
postprandial triglyceride concentrations. This triglyceride lowering effect of intermittent 
high intensity exercise was also observed in the fasted state (Bellou et al., 2013). While 
this does not represent a potential postprandial lowering, the effect on fasting levels helps 
build the case for intense exercise to lower blood triglyceride concentrations. To achieve 
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lower postprandial triglyceride levels, it may not be necessary to do as great of an 
intensity or complete the total duration in a single bout. A series of six, 5-minute bouts of 
running at 70% VO2max was shown to reduce postprandial triglyceride response as 
compared to a non-exercise control (Miyashita et al., 2009). However, it is important to 
note that these results did not investigate how intermittent exercise throughout the day 
compared to a single continuous bout of exercise (Miyashita et al., 2009). Another study 
conducted by Kim et al. (2014) furthered this notion that exercise may be done in an 
intermittent fashion and at a lower intensity. While the study found that a bout of 
moderate-intensity continuous running produced the greatest reduction in PPL, an 
accumulation of isoenergetic intermittent walking throughout the day still produced 
significant reductions in PPL as compared to a non-exercising control (Kim et al., 2014). 
This notion that PPL can be attenuated through low-intensity walking throughout the day 
suggests that a simple increase in non-exercise physical activity may be all that is 
necessary to improve blood lipid levels and subsequently improve cardiovascular health. 
 
2.3.4 Exercise-Induced Energy Deficit 
The impact of exercise induced energy deficit is another factor that has been 
explored to explain the reduction in PPL. Gill and Hardman (2000) investigated the 
relationships between exercise-induced and dietary-induced energy deficits on PPL as 
they observed prior research had not accounted for a relative energy deficit. This study 
found that, while an exercise-induced energy deficit (e.g. not replacing energy utilized 
during exercise via food) exhibited a significant reduction in PPL, a dietary-induced 
deficit did not. The results here suggested that some other mechanism was attributable to 
this PPL reduction (Gill & Hardman, 2000). The relationship between exercise-induced 
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energy deficit has been expanded upon with a notion that PPL reductions are only 
maintained when the energy deficit is not replaced by a meal (Burton, Malkova, Caslake, 
& Gill, 2008; Harrison et al., 2009). However, the abolishment of the PPL reductions 
with exercise-induced energy deficit may be related to the composition of the 
replacement meal. Both Burton et al. (2008) and Harrison et al. (2009) used either a 
moderate (~50%) or high (100%) carbohydrate replacement meal. Thus, the lack of 
difference found in PPL values may be due to carbohydrate replacement rather than 
something else. This notion of high and low carbohydrate replacement meals was 
investigated by Trombold et al. (2014) using a high carbohydrate content of ~83% and a 
low carbohydrate content of 12.5%. Although both replacement meals completely 
replaced energy lost via exercise, only the low carbohydrate meal maintained the 
reductions in PPL generally seen with exercise. The lack of PPL reduction in the 
moderate to high carbohydrate meals may be caused by a cascade of events stimulated by 
an influx of carbohydrate immediately post-exercise. Immediate intake of carbohydrate 
has been determined to be the most effective way to replenish muscle glycogen (Ivy et 
al., 2002; Ivy, Katz, Cutler, Sherman, & Coyle, 1988) especially when that carbohydrate 
is supplemented with protein (Ivy, Ding, Hwang, Cialdella-Kam, & Morrison, 2008). The 
amount of carbohydrate consumed in each of these tests may have been adequate to 
mostly or completely restore muscle glycogen levels (Costill et al., 1981) prior to a 
subsequent PPL test. However, if muscle glycogen levels have been supercompensated 
prior to complete carbohydrate uptake, insulin sensitivity will fall (Kuo, Browning, & 
Ivy, 1999), potentially leaving a large amount of carbohydrate in the blood to eventually 
be taken up elsewhere, particularly the liver. As mentioned before, the increase in 
carbohydrate in the liver may increase de novo lipogenesis, subsequently increasing 
VLDL secretion and PPL (Hellerstein, 1999; Nichols, 1969). 
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2.4 POTENTIAL ROLES FOR NON-EXERCISE PHYSICAL ACTIVITY 
Evidence has concluded that exercise is beneficial in improving postprandial 
triglyceride responses and endothelial function, which partially reduces the risk for 
developing cardiovascular disease. However, an increasing number of individuals are 
spending less time being physically active, let alone engaging in exercise, and more time 
being sedentary (Hansen, Kolle, Dyrstad, Holme, & Anderssen, 2012; Matthews et al., 
2008). An increasing body of evidence is suggesting that the risk for mortality increases 
as time spent sedentary, especially continuous sedentary time, increases (Dunstan et al., 
2010; Dunstan, Thorp, & Healy, 2011; Ekelund et al., 2016; Healy, Matthews, Dunstan, 
Winkler, & Owen, 2011; Katzmarzyk, Church, Craig, & Bouchard, 2009). However, the 
risks associated with increased sitting time may be reduced with adequate time spent in 
moderate-to-vigorous physical activity (MVPA) (Ekelund et al., 2016; Hamer, 
Stamatakis, & Steptoe, 2014; Howard et al., 2015; Katzmarzyk et al., 2009) or by 
breaking up sedentary time with adequate physical activity (Carter & Gladwell, 2016; 
Morishima et al., 2016; Thosar, Bielko, Mather, Johnston, & Wallace, 2015). To combat 
the increasing time spent sedentary, it is essential to identify effective ways to reduce the 
detrimental effects of sedentary time. 
 
2.4.1 Impact of Sitting on Postprandial Triglycerides 
Prolonged physical inactivity (e.g. prolonged sitting, bed rest, etc.) has been 
associated with insulin resistance, hypertriglyceridemia, ectopic fat storage 
(Bergouignan, Rudwill, Simon, & Blanc, 2011), and endothelial dysfunction (Morishima 
et al., 2016; Restaino et al., 2016). As it relates to prolonged sitting, PPL may be caused 
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by a reduction in muscular LPL activity. In a rat based model, heparin released LPL 
activity was significantly decreased, particularly in more oxidative muscle fibers, and 
triglyceride uptake was significantly decreased after a period of prolonged inactivity. 
These results suggest that muscle LPL is extremely sensitive to activity levels and may 
support the notion that a minimum level of physical activity must be reached to ensure 
adequate LPL activity and triglyceride uptake (Bey & Hamilton, 2003). These results 
were further supported by Zderic and Hamilton (2006) when they showed that inactivity 
suppresses LPL activity by ~90% in oxidative tissues. This reduction may be further 
exacerbated by an insulin resistance-mediated redistribution of energy towards VLDL 
production. As mentioned earlier, when insulin sensitivity falls, carbohydrate cannot be 
taken up into muscle and other tissue and will most likely be converted to VLDL in the 
liver (Hellerstein, 1999; Nichols, 1969). Olsen et al. (2008) were able to support the 
notion that increased physical inactivity leads to decreased insulin sensitivity and an 
increased triglyceride AUC. 
 
2.4.2 Physical Activity’s Ability to Attenuate PPL 
Finding the optimal amount of physical activity, whether it be exercise or non-
exercise (non-exercise activity thermogenesis; NEAT), is essential to reducing the 
incidence of cardiovascular disease through reductions in PPL driven atherosclerosis. A 
currently expanding field of research is beginning to suggest that physical activity and 
reductions in sitting time lead to reductions in metabolic and cardiovascular risk (Bey & 
Hamilton, 2003; Duvivier et al., 2013; Ekelund et al., 2016; Healy et al., 2008; Kim et al., 
2016; Peddie et al., 2013). As it relates to PPL, physical activity may restore or prevent 
the loss of LPL functionality seen with sitting, which would prevent the accumulation of 
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triglycerides in the blood (Bey & Hamilton, 2003). Some studies are also suggesting that 
intermittent physical activity breaks may also be more effective at reducing PPL than a 
single bout of continuous exercise (Duvivier et al., 2013; Healy et al., 2008; Peddie et al., 
2013). This improvement caused by regular breaks may also be mediated by 
improvements in glucose transport into cells (Peddie et al., 2013) or by increases in 
whole-body fat oxidation (Kim et al., 2016) that reduce the likelihood that endogenous 
triglyceride is produced and all sources of triglyceride are used for energy. However, 
some research is beginning to point out that current and emerging exercise 
recommendations (Ekelund et al., 2016; Garber et al., 2011) may not be enough to 
counteract the negative influences of sitting producing a so-called “exercise resistance” 
(Duvivier et al., 2013; Kim et al., 2016).  
In a study conducted by Duvivier et al. (2013), subjects were subjected to one of 
three free living activity regimes: sitting for 14-hours/day, sitting for 13-hours/day with 
the 1-hour of sitting replaced with 1-hour of vigorous exercise, and a minimal-PA routine 
with 8-hours/day of sitting, 4-hours/day of walking, and 2-hours/day of standing. Of note 
was the relationship of energy expenditure between the groups. While the exercising 
group only sat for 1-hour fewer than the sitting group, the exercise considerably raised 
energy expenditure. In addition, while the time spent in activity and the intensity of 
activity was different between the exercise and minimal-PA groups, the energy 
expenditure was equivalent (Duvivier et al., 2013). Interestingly, the 1-hour bout of 
exercise was not able to improve blood triglycerides, cholesterol, or insulin sensitivity 
over sitting alone. However, minimal-PA was able to improve blood triglycerides and 
cholesterol over sitting and additionally insulin sensitivity over the exercise group 
(Duvivier et al., 2013). A later study looking at the effects of sitting on exercise’s ability 
to normally lower PPL emphasized the role that sitting may play in health (Kim et al., 
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2016). In this study, subjects underwent three trials of 5-days: sitting for >14-hours/day 
with a hypercaloric energy balance, sitting for >14-hours/day with a eucaloric energy 
balance, and active walking/standing with ~8-hours/day of sitting, with a eucaloric 
energy balance, relative to the extra energy expenditure. On day 3, subjects underwent a 
HFTT. Following each trial, subjects performed a 1-hour bout of running and another 
HFTT. Results showed that regardless of energy balance, sitting for >14-hours/day 
diminished the ability of exercise to attenuate PPL or increase fat oxidation when 
comparing the second HFTT to the first (Kim et al., 2016). Unfortunately, the study 
design did not include a control trial that did not perform the bout of exercise on day 4. 
This omission may have led to the inability for the bout of exercise to reduce any of the 
metrics measured during the HFTT. Had there been a control group that did not perform 
exercise, it may have been possible to observe a decline in PPL, albeit blunted, or to truly 
determine that prolonged sitting abolishes the generally beneficial effects of exercise. 
These studies highlight the negative consequences that prolonged sitting may have, 
regardless of exercise or energy balance. It is thus imperative that research begins to 
understand how physical activity and exercise may reverse the effects of sedentary time 
or if the population needs to spend less time being sedentary to improve cardiovascular 
and metabolic health. 
 
2.5 SUMMARY 
Atherosclerosis and other cardiovascular diseases present a serious problem 
towards general public health and their causes are continually being uncovered. From 
dyslipidemia (Mozaffarian et al., 2015; Nordestgaard et al., 2007; Zilversmit, 1979) to 
endothelial dysfunction (Anderson et al., 1995; Davignon & Ganz, 2004), researchers are 
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beginning to understand the mechanisms that play into impaired cardiovascular health. 
However, rather than prescribe pharmaceutical intervention, the proposed benefits of 
physical activity and exercise to reduce the incidence of cardiovascular disease by 
controlling blood lipids and endothelial dysfunction seem to be a more cost-effective and 
an ideal method to reversing a startling trend that affects roughly 600,000 Americans 
every year (National Center for Health Statistics, 2016). While the study conducted by 
Kim et al. (2016) is a good starting point, the lack of a control group limits the 
revelations it can show. It is thus necessary to follow-up with the results found there to 
determine whether the PPL response to exercise is truly blunted by sitting and further 
demonstrate that prolonged sitting has deleterious effects on metabolic and 
cardiovascular health. Continued and extensive research is needed to understand how 
sedentary behavior drastically influences cardiovascular risk factors and how the 
mechanisms behind sedentary time and physical activity/exercise interact. 
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Chapter 3: Methodology 
3.1 RESEARCH PARTICIPANTS 
Ten healthy, untrained to recreationally active men (n=5) and women (n=5) 
participated in this study. Subjects were allowed to participate in the study if they were 
apparently healthy, did not have a history of cardiovascular or metabolic problems, were 
not on medication that would directly affect lipid or carbohydrate metabolism, and were 
able to participate in extended durations of moderate to vigorous activity. The 
Institutional Review Board of the University of Texas at Austin approved the recruitment 
of participants and the protocols used in this study. Participants were given verbal and 
written descriptions of all protocols and measurements and informed of the purpose and 
potential risks involved with this study. 
3.2 RESEARCH PROTOCOL 
All participants completed two different trials in a counterbalanced, crossover 
fashion, with each trial occurring over seven days with at least a week-long washout 
period between each trial. The first two days of each trial served as a control period (C1 
and C2) that allowed for familiarization and control for activity and diet prior to the 
intervention. Following this, subjects completed four days (D1-D4) during which they sat 
for ~13.5 hours per day. On the evening of D4, the sitting with exercise group (SIT+EX) 
performed a 1-hour bout of exercise at ~65% VO2max on a laboratory treadmill. On the 
morning of day five (D5), all subjects ingested a high fat shake (i.e. high fat tolerance 
tests; HFTT) and PPL responses were measured over the subsequent 6-hour period. A 
pictorial description is provided in Figure 1. Prior to partaking in any of the experimental 
conditions, subjects visited the Human Performance Laboratory (HPL) to undergo 
submaximal and maximal oxygen uptake (VO2max) testing that was used to determine the 
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relative intensity of the exercise bout each participant performed on D4 in the SIT+EX 
group. In addition, subjects had their resting metabolic rate (RMR) measured at this time. 
During the initial visit, each subject had the study explained to them, signed an informed 
consent, and was able to ask any questions. Following the submaximal and maximal 
exercise testing, subjects were instructed on the proper way to use and attach the activity 
monitor.  
During each trial, participants refrained from any exercise and kept physical 
activity to a minimum to achieve >13 hours per day of sitting. The diet followed was 
standard in macronutrient breakdown (US Department of Health and Human Services, 
2011) and eucaloric such that subjects replaced the approximate number of calories 
needed as determined by RMR. Subjects in the SIT+EX group also consumed additional 
calories (via commercially available protein bars; Clif® Builder’s®; approximately 40% 
carbohydrate, 30% fat, 30% protein) following the exercise bout to offset those lost 
during exercise. On the evening of D4, participants consumed a low-fat meal as fat in the 
previous meal can affect the response to a high-fat test meal (HFTM) (Fielding et al., 
1996; Trombold et al., 2014) and the SIT+EX group performed their one-hour bout of 
exercise. On the morning of D5, participants went through an HFTT at ~0800 hours 
following a 12-hour fast. Prior to the HFTT, subjects arrived at 0700 hours and had 
weight measured, baseline expired gas measured, and a blood sampling catheter inserted. 
A resting blood sample was taken and then the HFTM was consumed in 5-minutes. 
Blood samples were then taken hourly for the next 6-hours. During the HFTT, expired 
gas was collected for determination of carbohydrate and lipid metabolism. Participants 
had been resting for at least 15-minutes in a relaxed, seated position, followed by 10-
minutes of expired gas collection via meteorological balloons performed at 2, 4, and 6-
hours post-HFTM ingestion. For the duration of each HFTT, participants sat quietly 
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reading, watching movies, and/or browsing the Internet. Participants were allowed to use 
the nearby restroom.  
During C1 and C2, participants were asked to refrain from planned exercise, but 
achieve ~7,000 steps/day, corresponding to a “low level of physical activity” (Tudor-
Locke & Bassett, 2004). On D1-D4 participants went through one of two conditions: 
prolonged sitting (~13.5 hours/day) without acute exercise (SIT) or prolonged sitting with 
1-hour of acute exercise (SIT+EX). During the SIT+EX trial, the bout of exercise 






Figure 1: Pictorial representation of experimental design 
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3.3 MEASUREMENTS 
3.3.1 Anthropometric Measurements 
Subject body mass, as taken by a digital scale (Ohaus, CW-11, Parsippany, NJ). 
and recorded to the nearest 0.05 kg, was measured prior to any testing done at each visit. 
Height was measured using a standard stadiometer during the initial visit. Body mass and 
height were used to calculate BMI as a ratio of body mass to height squared. 
3.3.2 Blood Sampling and Analysis 
After 12-hours of overnight fasting, blood was collected during the HFTT via 
antecubital venous catheter. Approximately 4 mL of blood was taken for analysis at each 
draw during the HFTT at regular intervals (Pre, 1, 2, 3, 4, 5, and 6-hours post-meal). 
Prior to catheter insertion, the location of insertion was identified, cleaned, and sterilized 
thoroughly with an alcohol preparation wipe. After catheter insertion, a one-way valve 
and line was attached to allow for both blood collection and saline flush. When blood was 
not being drawn, a syringe filled with sterile normal saline was attached to the valve to 
allow for 1 mL of saline to be flushed through the line periodically (approximately every 
5-10 minutes) to ensure patency. Catheters were inserted by a certified phlebotomist. 
After blood was transferred to K2 EDTA tubes (BD Vacutainer, Fisher Scientific, 
Hampton, NH), the tube was then centrifuged at 3,000 revolutions per minute at 4°C for 
15-minutes. Plasma was then aliquoted from the K2 EDTA tube to an available 
Eppendorf tube labelled with identical subject information. The Eppendorf tubes were 
then stored at -80˚C in a locked laboratory freezer until later analysis. After blood 
samples were analyzed, they were discarded according to The University’s 
Environmental Health and Safety guidelines. Plasma glucose was measured by a 
spectrophotometric method using commercially available kits (Pointe Scientific, Inc. 
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Canton, USA). Plasma triglyceride was also measured using a spectrophotometric 
method using commercially available kits (Pointe Scientific, Inc., Canton, USA). 
Appendix C contains detailed descriptions of each analysis performed. 
3.3.3 Diet 
Diet during each control period was kept constant and remained the same for each 
trial. During each experimental trial, diet was maintained at a eucaloric level as estimated 
from resting metabolic rate. Subjects were asked to achieve a diet that would provide a 
standard macronutrient breakdown (US Department of Health and Human Services, 
2011). In addition, all food was logged using the free MyFitnessPal program/mobile 
application (MyFitnessPal, Inc.) and subjects were asked to consume the same food from 
Trial 1 in Trial 2. Additional energy expenditure from exercise sessions was estimated via 
indirect calorimetry using gas analyzers and was then replaced with additional food post-
exercise. Food was provided for the subject on Day 4 to ensure strict adherence to a 
particular macronutrient profile, as certain meals in the 24-hours prior to HFTT can 
greatly impact postprandial triglyceride concentration, particularly the previous meal to 
the HFTM (Trombold et al., 2014). During the HFTT, the test meal was composed of 
portions of melted ice cream and half-and-half creamer to achieve a macronutrient and 
caloric profile based on body weight (carbohydrate = 1.12g/kg, fat = 1.20g/kg, protein = 
0.35g/kg; total calories = 16.8kcal/kg). 
3.3.4 Heart Rate 
Heart rate was recorded and logged during exercise bouts via wearable heart rate 
monitor (HRM) (Polar Electro Inc., Lake Success, NY). 
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3.3.5 Maximal and Submaximal Exercise Tests 
Submaximal exercise testing was conducted on a treadmill at 0% grade with 4 
stages of increasing speed, with each stage lasting 5-minutes in duration. This served to 
determine oxygen uptake (VO2) during moderate intensity exercise as well as 
approximate the intensity needed to reach 75% of VO2max to be used as the starting point 
for subsequent VO2max tests and 65% of VO2max for the 1-hour bout of exercise. After 15-
20 minutes of rest, participants completed a graded VO2max test using a progressive 
treadmill protocol designed to last 8-12 minutes. Participants began at a speed that 
elicited 75% of VO2max at 0% elevation for 4-minutes. At 4-minutes, the elevation was 
brought to 4%. At 6, 8, and 10-minutes, the elevation was brought to 6%, 8%, and 10%, 
respectively. If the subject was able to continue after this, the elevation was increased 2% 
every 1-minute until volitional exhaustion was reached. Gas analysis was performed 
using oxygen and carbon dioxide analyzers (Applied Electrochemistry, Models S-3A/I 
and CD-3A, respectively) while the subjects breathed through a one-way valve (Hans 
Rudolph, Kansas City, MO). Ventilation was measured via an inspiratory 
pneumotachometer (Hans Rudolph, Kansas City, MO). VO2max was confirmed by at least 
2 of the 3 following measures: a leveling off of oxygen uptake despite increasing 
intensity, HR within ±12 beats/min of age-predicted max (Predicted HRmax = 208 – 
0.7*(age)), and a rating of perceived exertion (RPE) of 17 or higher out of 20 (Borg, 
1982). 
3.3.6 Physical Activity Monitoring and Step Monitoring 
Levels of physical activity/inactivity were monitored almost continuously over 
the course of 6.5-days using a small, noninvasive monitor (activePALµ, PAL 
Technologies, Glasgow, Scotland). This activity monitor measured roughly 2in x 1in x 
0.1in in size and was worn anteriorly on the thigh, roughly halfway between the inguinal 
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crease and the proximal border of the patella. The monitor was placed in a small rubber 
sheath and attached via transparent film dressing. The activity monitor was not 
waterproof and could not be worn while showering. Subjects were thus instructed to 
remove the device prior to showering and were provided with the materials to change the 
dressing immediately after showering once the area was dry. The monitor was attached 
on the evening prior to C1 and was only removed for 30-minutes each day to allow for 
time to shower. The monitor was used to make differentiations between a variety of 
activities, including supine/sitting, standing, and stepping. The same monitor was used to 
track step count. This device was able to determine all of this information through a 
combination of accelerometers and inclinometers. A further pedometer, either a standard 
pedometer or one accessed via smartphone, was used by the participants to use as visual 
feedback for daily step count as the normal monitor did not provide feedback until synced 
to a computer.  
3.3.7 Postprandial Gas Exchange/Resting Metabolic Rate 
Postprandial metabolic gas measurements and resting metabolic rate (RMR) gas 
measurements were performed via meteorological balloons. Participants were seated in a 
relaxed manner for 15-minutes, followed by gas collection for 10-minutes. During 
postprandial and RMR measurements, subjects breathed through a one-way valve (Hans 
Rudolph, Kansas City, MO) that was directly attached to a meteorological balloon. This 
gas sample was allowed to sit for 15-minutes before a 6-foot capillary sampling line was 
inserted via three-way stopcock to measure O2, CO2, and N2 concentrations via mass 
spectrometer (Perkin-Elmer MGA 1100, St Louis, Missouri). Expired gas volume was 
then determined by connecting the meteorological balloon to a spirometer (Vacumed, 
Ventura, CA) and passing the air through. 
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3.4 STATISTICAL ANALYSIS 
Incremental (AUCi) and total area under the curve (AUCt) for plasma 
concentrations of triglyceride (TG) and glucose were calculated using the trapezium rule. 
Once calculated, paired, two-tail t-tests were used to test for differences. Daily step 
count, caloric intake, and time spent in each posture/activity were analyzed using one-
way ANOVA. Fasting and postprandial responses of respiratory exchange ratio (RER), 
fat oxidation, glucose, and TG were analyzed using two-way ANOVA with repeated 
measures (trials and time). Post-hoc Bonferroni corrections were performed to determine 
if statistical significance exists. All data were analyzed using GraphPad Prism 7 
(GraphPad Software, Inc., La Jolla, CA). All data are presented as means and standard 
error of the mean (SEM), unless otherwise noted. The level for statistical significance 
was set at α=0.05 
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Chapter 4: Results 
4.1 SUBJECT CHARACTERISTICS 
Subject characteristics are outlined in Table 1. The total number of subjects was 
10 (5 males, 5 females), with each subject completing both experimental trials. Subjects 
were mostly considered healthy, college age (23.8±4.0 years old) individuals that were 
untrained to recreationally active with a relative VO2max of 43.43±10.02 mL•kg-1•min-1. 
Subject HR, %VO2max, and RPE during the one-hour bout of exercise were suggestive of 





 Age (y) 23.8±4.0 
Height (cm) 173.1±14.4 
Body Mass (kg) 83.0±28.1 
BMI (kg·m-2) 27.06±5.72 
Resting Energy Metabolism 
 RMR (kcal/day) 2302.1±694.9 
Maximal Exercise Response 
 VO2max Absolute (mL·min-1) 3565.82±1260.24 
VO2max Relative (mL·kg-1·min-1) 43.43±10.03 
Response to Exercise Bout 
 Heart Rate (bpm) 158.14±10.98 
Rating of Percieved Exertion 11.8±2.15 
VO2 (mL·kg-1·min-1) 27.45±6.96 
%VO2 max 63.07±5.18 
Table 1: Participant information (Body Mass Index, BMI; Resting 
Metabolic Rate RMR) 
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4.2 ENERGY INTAKE 
Energy intake for each day of both trials was recorded (Table 2 and Figure 2). For 
both control days (C1 and C2) and the first three days of the intervention (D1, D2, and 
D3), there was no difference in energy intake as subjects were asked to consume the 
exact same diet during Trial 2 that was consumed during Trial 1. By design, there was a 
significant interaction between trials (SIT and SIT+EX) and time (day) on D4 as the 
approximate caloric expenditure from exercise was fed to the subjects in addition to their 
normal provided meals (p<0.001). Post hoc analyses confirmed that the SIT+EX group 
consumed more calories than the SIT group on D4 (p<0.001). The added meal post-
exercise was consumed with dinner immediately after the bout of exercise and was met 
via the use of Clif® Builder’s® with the calories coming from approximately 40% from 
carbohydrate, 30% from fat, and 30% from protein. Energy intake during the HFTT also 
demonstrated no difference. 
4.3 DAILY STEPS AND BODY POSTURE/ACTIVITY 
Daily steps (Table 2 and Figure 3), as well as time spent sitting/supine, time spent 
standing, and time spent stepping (Table 2 and Figure 4) were recorded.  A significant 
interaction was found between trials (SIT and SIT+EX) and time (day) for daily step 
count (Figure 3). Post hoc analyses determined that the SIT+EX group took significantly 
more steps than the SIT group on D4. There were no differences between the SIT and 
SIT+EX groups for time spent sitting (Figure 4A) or time spent standing (Figure 4B). 
However, there was a significant interaction between treatment (SIT and SIT+EX) and 
time (day) for time spent stepping (p<0.001). Post hoc analyses determined that on D4, 
the SIT+EX group stepped significantly more times than the SIT group (p<0.001). These 
differences were caused by the one-hour bout of exercise performed on D4.  
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Figure 3: Average daily step count (steps/day) for both trials shown above. 
Control days (C1 and C2), intervention days (D1, D2, D3, and 
D4), and HFTT (D5) all represented.  *Significantly different 
interaction between trials (p<0.001)  
Figure 2: Average daily caloric intake (kcal/day) for both trials shown above. 
Control days (C1 and C2), intervention days (D1, D2, D3, and 
D4), and HFTT (D5) all represented.  *Significantly different 
interaction between trials (p<0.001) 




























































































































































4.4 POSTPRANDIAL SUBSTRATE OXIDATION 
Postprandial substrate oxidation was determined using indirect calorimetry (Lusk, 
1924) (Table 3 and Figure 5). Oxidation calculations were limited to five paired subjects 
due to apparent hyperventilation at rest as defined by a respiratory exchange ratio (RER) 
greater than 1.00. RER was not found to be different between trials (Figure 5A). Percent 
carbohydrate oxidation (Figure 5B) and percent fat oxidation (Figure 5C) were found to 
have no difference between trials at any time point postprandial. Finally, no difference 
was found in postprandial energy expenditure (Figure 5D). While no difference was 
Figure 4: Time spent sitting/supine (A), time spent standing (B), and time spent stepping 
(C) are represented above. *Significantly different interaction between trials 
(p<0.001) 




















































Figure 5: Postprandial substrate oxidation during HFTT. RER (A), percent carbohydrate 
oxidation (B), percent fat oxidation (C), and energy expenditure (D) are 
shown above. No significant differences were found at any time point 
between trials. 
































































































4.5 PLASMA TRIGLYCERIDE CONCENTRATIONS 
Plasma triglyceride concentrations were analyzed at each measured time point in 
both trials and as the incremental area under the curve (AUCi) and total area under the 
curve (AUCt). No significant difference was found between trials at any time point for 
the triglyceride curve. Individual time points within each trial were significantly 
different, however, when compared to either Baseline or Hour 1 (Table 4 and Figure 6A). 
Table 3: Average values for postprandial substrate oxidation variables for duration of 
HFTT. (&) Significantly different from Baseline (p<0.05), (#) 
significantly different from Baseline (p<0.01), (*) significantly different 
from Hour 2 (p<0.01) 
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In addition, neither AUCi nor AUCt demonstrated a significant difference between trials 
(Table 5 and Figure 7). 
4.6 PLASMA GLUCOSE CONCENTRATIONS 
Plasma glucose concentrations were analyzed at each measured time point in both 
trials and as the incremental area under the curve (AUCi) and total area under the curve 
(AUCt). As with the triglyceride concentrations, no significant differences were found at 
any time point between trials. However, significant differences were found at different 
time points within each trial’s HFTT (Table 4 and Figure 6B). Furthermore, neither AUCi 




















Figure 6: Plasma concentration response for triglyceride (A) and glucose (B) during the 
HFTT for both trials. No significance was found between trials in either 
measurement (p>0.05). 































































































































































































































































































































































































Table 5: Incremental and Total areas under the curve for both 
triglyceride and glucose responses during HFTT. No 
significant differences were found between trials. 
Figure 7: Triglyceride AUCt (A) and AUCi (B) for both trials. No significant 
difference was found between trials in either measurement (p>0.05). 
Figure 8: Glucose AUCt (A) and AUCi (B) for both trials. No significant difference was 
found between trials in either measurement (p>0.05). 
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Chapter 5: Discussion 
The main purpose of this study was to investigate the effect of several days of 
prolonged sitting on the ability of an acute bout of exercise to reduce PPL. In order to 
assess this interaction, the study had two, one week-long interventions that had 
participants perform four days of prolonged sitting (~13.5 hours/day) with one 
intervention containing a one-hour bout of moderate intensity (~63% VO2max) exercise. 
The main hypothesis was that there would be no difference in the PPL response to a 
HFTT after the fourth day, despite the SIT+EX group receiving the one-hour bout of 
exercise. As hypothesized, the study was able to demonstrate that metabolic outcomes 
(e.g. plasma triglyceride and glucose concentration) were no different in the SIT+EX as 
compared to the SIT group, suggesting that the prolonged sitting abolished the ability of 
the acute bout of exercise to reduce PPL response. 
Although it has been well documented that exercise is effective at lowering PPL 
and plasma glucose (Beidleman et al., 2008; Herd et al., 2001; Malkova et al., 2000; 
Zhang et al., 1998), more recent research (Duvivier et al., 2013; Kim et al., 2016) has 
shown that prolonged sitting or sedentary activity may invoke a type/form of “exercise 
resistance.” While both Duvivier et al. (2013) and Kim et al. (2016) demonstrated this 
relationship between prolonged sitting and PPL, both studies exhibited missing elements 
of their design. The study by Duvivier et al. (2013) was limited to the examination of the 
effect of an oral glucose tolerance test after prolonged sitting, prolonged sitting with 
exercise, and physical activity throughout the day. While glucose tolerance is important, 
as it relates to atherosclerosis, triglyceride tolerance would be a better metric as 
postprandial triglyceride tolerance is more highly related to risk of cardiovascular disease 
(Bansal et al., 2007; Nordestgaard et al., 2007).  While Kim et al. (2016) did look at 
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triglyceride tolerance, all three groups that were investigated performed the bout of 
exercise. The results thus focused less on the effect of the bout of exercise and more on 
the dietary differences and activity differences. This could be seen as a limitation to the 
design as there was effectively no control group used to investigate the effects of a one-
hour bout of acute exercise. The current study was subsequently modeled after the Kim et 
al. (2016) study, but with only two groups. In using only two groups, one of them being a 
control that did not exercise (SIT), we could isolate the effects of exercise as everything 
else was kept controlled between trials. This extended to the fact that caloric intake in 
both groups was maintained close to energy balance, particularly D4, when subjects in 
SIT+EX were fed an average of 650 kilocalories.  
In the present study, the goal was to emulate conditions that would be common in 
real world scenarios. Much like the Kim et al (2016) study, subjects were seated or 
supine for the vast majority of their intervention days. While the activity monitor could 
not distinguish between seated and supine time and subsequently sleeping time, under the 
assumption of an average 7-8 hours of sleep per night, subjects were still seated for over 
half their day and the vast majority of their waking hours. This extended time spent 
sitting helps connect these results to real world application as sitting is the predominant 
form of physical inactivity (Hamilton, Hamilton, & Zderic, 2007). In addition, subjects 
averaged <4,000 steps/day during each intervention outside of the 1-hour bout of 
exercise, which would be indicative of a sedentary lifestyle (Tudor-Locke & Bassett, 
2004), beyond the time spent sitting. Given that no differences were found between daily 
steps, body posture/activity, or caloric intake, except for the day of the exercise bout, this 
level of sedentary behavior was maintained in both trials. 
When looking at triglyceride and glucose responses, it was important to look at 
the temporal responses to see how PPL changed over time, but also at the area under the 
 39 
curve (AUC) to quantify the overall response to the high fat test meal. While a difference 
was not seen between trials for the temporal response in plasma triglyceride or glucose 
concentrations, there was a significant difference found at different time points with each 
trial. This within trial response was to be expected, however, as the absorption of glucose 
and triglyceride is a delayed response. Plasma glucose generally peaks soon after 
ingestion and begins to fall off after that while plasma triglyceride generally takes about 
2-hours post-ingestion to begin increasing, eventually peaking about 3-4 hours post-
ingestion. While plasma triglyceride followed the trend that would be expected, the 
average plasma glucose took slightly longer to peak and remained high through ~4-hours 
postprandial. Two reasons may help explain this observation. The first is that the 
wavelength filter used in the microplate reader for plasma assay analysis had a relatively 
wide range, which may have reduced the accuracy of our measured concentrations of 
glucose. The second reason may be that the introduction of high levels of fat in the diet 
may reduce the glycemic response to a high carbohydrate meal (Jenkins et al., 1981), 
delaying the peak, and it may reduce the uptake of circulating glucose (Boden & Chen, 
1995), extending the time plasma glucose stays elevated. However, as the study was set 
up in a crossover fashion and both trials underwent the HFTT, the difference in 
metabolism should have been derived from the exercise bout alone, if any difference 
existed. Furthermore, the plasma glucose results in the study by Kim et al. (2016) also 
exhibited this prolonged response. 
Looking at the AUC for both triglyceride and glucose response, the PPL response 
can be better evaluated. As noted previously, no significant difference was found between 
trials in AUCt for either triglyceride or glucose. This would suggest that sedentary 
behavior not only abolished the normal effects of exercise to reduce PPL not only across 
the test, but via the overall response as well. However, it has been suggested the AUCt is 
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not the most appropriate test as it does not accurately reflect the rise in PPL (Carstensen, 
Thomsen, & Hermansen, 2003). Carstensen et al. (2003) suggests that AUCi should be 
used instead as it has a stronger relationship with the postprandial triglyceride response 
and accounts for basal differences. However, when we examined the AUCi for both 
triglyceride and glucose, we still found no significant difference between trials. The lack 
of difference between trials for glucose and triglyceride in either AUCt or AUCi 
continues to suggest that prolonged sitting and sedentary behavior significantly affect 
triglyceride and glucose metabolism. As it relates to cardiovascular disease, the impaired 
triglyceride metabolism seen after prolonged sitting may lengthen the amount of time 
atherogenic byproducts are in contact with the vasculature. This increased exposure to 
these byproducts may be increasing the rate of atherogenesis and subsequent 
cardiovascular problems as has been previously elucidated (Assmann et al., 1996; 
Jeppesen et al., 1998; Manninen et al., 1992; Zilversmit, 1979). 
Substrate oxidation as calculated by indirect calorimetry might be able to show 
improved metabolic outcomes despite no difference in plasma profiles of triglycerides or 
glucose. If caloric expenditure were to remain the same from trial to trial, but SIT+EX 
were to demonstrate a higher percentage of energy expenditure from fat, then more of the 
circulating lipid might be oxidized. However, indirect calorimetry did not show a 
significant difference between RER, percent substrate from carbohydrate, percent 
substrate from fat, or total energy expenditure. This would suggest that beyond the effects 
that prolonged sitting has on circulating triglyceride and glucose, this sedentary behavior 
also has negative effects on substrate oxidation. However, the lack of a difference in gas 
analysis may be due to the small sample size. Perhaps due to the lack of experience with 
or comfort with the mouthpiece and one-way valve that was used to collect expired gas 
samples, three subjects consistently hyperventilated (as indicated by an RER over 1.00) 
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in both trials while two more subjects hyperventilated in one trial. This limited the 
number of subjects that could be analyzed for indirect calorimetry and may have reduced 
the ability to detect a difference between trials. 
Although this study demonstrated that prolonged sitting, even with a one-hour 
bout of moderate exercise, has detrimental effects on triglyceride and glucose clearance, 
it did not directly investigate the mechanisms for exercise resistance and requires 
speculation. Lipoprotein lipase (LPL), particularly at the muscular level, is perhaps one 
of the first explanations for the impaired triglyceride clearance that has been observed. 
LPL has been observed to upregulate post-exercise for ~24-hours as extra binding sites 
appear along the luminal wall of the vasculature (Herd et al., 2001; Herd et al., 2000; 
Kantor et al., 1984; Maraki & Sidossis, 2013). This would generally be significant as 
LPL hydrolyzes the triglyceride attached to chylomicron and VLDL carriers to allow for 
uptake into the adjacent cells (Ginsberg et al., 2005) and is the rate-limiting enzyme for 
removing chylomicrons and VLDL from circulation (Wang & Eckel, 2009). However, 
due to the lack of difference in postprandial plasma triglyceride concentration found in 
the present study, it may suggest that prolonged sitting impaired or prevented the 
upregulation of LPL post-exercise. In fact, studies have shown prolonged inactivity 
decreases the amount of heparin released LPL and may reduce its activity by up to 90% 
(Bey & Hamilton, 2003; Zderic & Hamilton, 2006). LPL activity may not be the only 
cause of impaired PPL response. 
Insulin sensitivity may be another mediator for impaired PPL response. It has 
been suggested that a reduction in daily activity may cause a decrease in insulin 
sensitivity (Olsen et al., 2008). This may be particularly pronounced in the disused 
muscles, potentially suggesting that a lack of muscular activity may be the cause for this 
reduction in insulin sensitivity (Krogh-Madsen et al., 2010). This relationship between 
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insulin resistance and dyslipidemia seems relatively linear as well, suggesting that 
dyslipidemia becomes more pronounced with an increase in insulin resistance (Reaven, 
1993). These findings point towards an increase in dyslipidemia as a result of the 
physical inactivity derived insulin resistance. This relationship may occur due to the 
subsequent increase in circulating glucose. As the tissues, particularly muscle, are unable 
to take up glucose as effectively, the circulating glucose is more likely to be picked up in 
the liver and, via de novo lipogenesis, are converted to VLDL (Hellerstein, 1999; 
Nichols, 1969). This conversion from carbohydrate to lipid would greatly increase the 
PPL response. Furthermore, given the high concentration of carbohydrate used in the test 
meal, that may have been enough to stimulate this lipogenesis. However, rather than 
impaired glucose uptake influencing triglyceride uptake, other research suggests that the 
increase in circulating lipid actually affects glucose uptake (Boden & Chen, 1995). This 
suggests the possibility that the impaired PPL response is in part caused by the 
concomitant rise in glucose due to insulin resistance or that insulin resistance is imbued 
by the hyperlipemic response to the test meal. It is difficult to discern the difference in 
this study at the time, however, as insulin is not reported in this thesis. However, it might 
be postulated that the response to insulin secretion was similar as the plasma glucose 
response was similar between trials in response to a comparable meal. 
While the present study helped answer the missing part of the design from the 
Kim et al. (2016) study, it is not without its limitations. First the sample size may not 
have been large enough to detect appreciable differences in our dependent measures. 
However, three more subjects were used in the present study than in the Kim et al. (2016) 
study, which may have improved our chances to find significant differences. Secondly, 
activity was not as controlled as it could possibly be, but to do so would require removing 
each individual from their normal routine and have them spend the duration of each week 
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in the laboratory. Doing so is highly unrealistic for the scope of this project, but it may be 
important in future studies to ensure adequate control over the subjects’ lifestyles. 
Finally, the feeding back of the calories expended during the bout of exercise may have 
been the cause of the impaired PPL response in the SIT+EX as the replacement of energy 
lost has been reported to attenuate the exercise induced PPL reduction (Burton et al., 
2008; Harrison et al., 2009), especially when the meal is high in carbohydrate (Trombold 
et al., 2014). In this study, however, the percentage of carbohydrate in the replacement 
meal was moderate (~40% energy from carbohydrate) and perhaps lower than the 
percentage of carbohydrate in a standard diet (US Department of Health and Human 
Services, 2011) In addition, the extra caloric intake resulting in a eucaloric balance post-
exercise on D4 has been shown to produce a similar PPL response to a condition in which 
the exercise causes hypocaloric balance (Kim et al., 2016). Thus, the extra caloric intake 
on D4 of the SIT+EX trial most likely did not contribute to the impaired PPL response 
observed. 
In conclusion, the data in the present study points to the notion that four days of 
prolonged sitting has detrimental effects on normal, exercise-induced metabolic 
responses. Rather than the reduction in triglyceride and glucose responses that would be 
expected after a one-hour bout of acute exercise, the results demonstrated no difference 
compared to the control group. The findings in this study suggest that sitting generates a 
resistance to exercise that cannot simply be overcome by an acute exercise bout. This 
highlights the need to look at several bouts of exercise, perhaps those that meet current 
exercise recommendations (Garber et al., 2011) or proposed non-exercise physical 
activity recommendations (Ekelund et al., 2016). The findings in this study coupled with 
those by Kim et al. (2016) emphasize the detrimental consequences prolonged sitting has 
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on human cardiometabolic health and underscores the need for further research to 
determine the best course of action of avoid the negative impact of prolonged sitting.  
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Appendix A: Informed Consent 
Consent for Participation in Research 
 
 





The purpose of this form is to provide you information that may affect your decision as to 
whether or not to participate in this research study. The person performing the research 
will answer any of your questions. Read the information below and ask any questions you 
might have before deciding whether or not to take part. If you decide to be involved in 
this study, this form will be used to record your consent. 
 
Purpose of the Study 
 
The purpose of this study is to investigate the effect of 4 days of sitting, and moderate 
exercise on plasma triglyceride elevation after a meal. 
 
What will you be asked to do? 
 
Before you can be admitted to the study, you will be given brief preliminary tests. This 
will include filling out a brief Health Research Questionnaire, and taking measurements 
of your height and weight. Only if you are apparently healthy and at low risk for 
cardiovascular disease will you be invited to participate in this study. Prior to your 
enrollment in the study, your maximal oxygen uptake (VO2max) will be determined while 
running on a treadmill and also your heart rate during submaximal running will be 
determined. 
 
Each trial will require seven days, with periodic visits to the HPL: 
 
Trial 1: Plasma triglyceride responses with four days of mostly prolonged sitting. 
 
Trial 2: Plasma triglyceride responses with four days of mostly prolonged sitting and a 
single one-hour bout of exercise on the night of the fourth day. 
 




Week prior to the initiation: Health history questionnaires, familiarization, VO2max test. 
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1. Arrival at the Human Performance Laboratory (HPL), informed consent, health history 
questionnaires, body mass and height. 
2. Installation of the activity monitor. 
3. Perform resting gas measurement. 
4. Warm up for 5 minutes on a treadmill. 
5. Perform submaximal exercise test with four treadmill speeds lasting five minutes each. 
The intensity will approximate 40, 60, 70 and 80% of age predicted maximal heart rate. 
6. Recover for ~ 15-20 minutes (re-hydrate to pre-exercise bodyweight) 
7. Perform continuous maximal oxygen consumption test; (VO2maxtest, 8-12 min.) 
 




Control Phase: Control Day 1 and 2 (C1 and C2) 
 
Day prior to Control day 1: Activity monitor installation 
 
1. Arrival at the laboratory any time before 17:00 h. 
2. Installation of activity monitor 
 
- Total time: 30 minutes 
 
■ Total time spent during Control Phase: 30 minutes 
 
Intervention Phase: D1 - D4 
 
Day 1-3: Sitting 
 
For a both interventions, Sitting and step number (~2,000 steps) 
 
1. Sitting in preferred place (>12 hours, not necessarily in HPL). 
2. Arrival at HPL at 17:00 h on D3. 
3. Meals for D4 provided in the laboratory. 
 
- Total time: 30 minutes 
 
Day 4: Sitting, or Sitting & 1-hr treadmill running 
 
For SIT, sitting and step number (~2,000 steps) 
 
1. Sitting in preferred place (>12 hours, not necessarily in HPL). 
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2. Arrival at HPL at 17:00 h. 
3. Dinner provided in the laboratory 
 
For SIT- EX, sitting and a single bout of 1-hour exercise at 65% 
 
1. Lying or sitting in their preferred place (>12 hours). 
2. Arrival at HPL at 16:50 h. 
3. Exercise at 65% VO2max for one hour at around 17:00 h 
4. Dinner provided in the laboratory. 
 
- Total time: SIT- 30 min; SIT-EX- 120 min 
 
Day 5: High fat tolerance test and resting fat oxidation 
 
1. Arrival at HPL, body weight, 8:00 h. 
2. Catheter insertion and fasting blood collection. 
3. High fat shake intake 
4. Postprandial blood sampling hourly for 6 h (6 additional samples) 
5. Expired gas collection for 20 minutes at 1, 3, 5 h after high fat shake intake 
6. Detachment of the activity monitor 
 
- Total time: 420 minutes 
 
■ Total time spent during Intervention Phase: 
 
- SIT: 480 minutes 
 
- SIT+EX: 570 minutes 
 
Total time per subject for both trials is approximately 1,050 minutes   
 
What are the risks involved in this study? 
None of the above procedures are expected to be unduly painful or unsafe in healthy 
individuals. The maximal oxygen uptake (VO2max) and submaximal tests and 1 hour of 
moderate exercise at 65% VO2max will be performed at 20 - 25ºC and relative humidity of 
~ 50%. During VO2max test, only the final 2 to 4 minutes of the test is at or near maximal 
levels of exertion and thus accompanied by a sensation of leg fatigue and heavy 
breathing. This moderate feeling of fatigue will subside soon after completion (i.e.; 2-10 
min). There is a very small risk that participants could experience a muscular injury, such 
as muscle strain. It is also possible that muscle soreness may develop 24 to 48 hours after 
any given testing session. To help reduce these risks, a warm up session will be 
mandatory prior to performing these tests. 
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Blood samples will be drawn during each HFTT via venous catheter in the forearm or 
antecubital vein. A certified phlebotomist will insert the catheters. Minor discomfort may 
occur during the insertion of the catheter. The discomfort associated with the insertion of 
the catheter is similar to a venipuncture. Risks associated with placement of the catheter 
include bleeding, pain, swelling, bruising, infection, and thrombophlebitis. 
Approximately 42 ml of blood will be drawn per trial. Over the course of the entire study 
approximately 84 ml of blood will be drawn. This sample volume is approximately 6 
tablespoons and <1.5% of the individual’s total blood volume. If participants are found to 
have abnormally high triglyceride levels, they will be alerted of this and advised to 
follow-up with their primary care physician. 
 
The activity monitor will be instrumented the day before each trial after taking a shower 
and will be equipped for 96 hours. Participants may experience a low-level annoyance 
from the wires touching the skin during the 48hr monitoring based upon previous 
practices in the lab. The activity monitor will be detached for 1 hour to load data to a 
computer, during which participants will take a shower on day 4 (the intervention day). 
Thus, participants will not be allowed to take a shower when the activity monitor is 
attached to the participants. A pedometer will be instrumented for a week before the 
initiation of the first trial for the estimation of an average daily step and throughout the 
trials. It will not give participants any discomfort as many use such instrumentation 
regularly. 
 
The risk of any sort of cardiovascular complication in apparently healthy (no documented 
CV disease) individuals is very low, with no complications in 380,000 tests. Furthermore, 
in over 32 years involving more than 50,000 exercise sessions, no subject in the Human 
Performance Lab has experienced any cardiac event. The laboratory is currently equipped 
with AED. A CPR certified member of the research team will be present during all 
testing visits in the unlikely event of an adverse reaction. 
 
During the tests participants may stop performing the task at any time and for any reason 
if he or she feels the need to do so. If participants wish to discuss the information above 
or any other risks participants may experience, participants may ask questions now or call 
the Principal Investigators. 
 
What are the possible benefits of this study? 
 
You will receive no direct benefit from participating in this study; however, each subject 
completing the study will be provided with a graphic and verbal description and 
explanation on their maximal aerobic capacity, heart rate, blood pressure and metabolic 





Do you have to participate? 
 
No, your participation is voluntary. You may decide not to participate at all or, if you 
start the study, you may withdraw at any time. Withdrawal or refusing to participate will 
not affect your relationship with The University of Texas at Austin (University) in 
anyway. 
 
If you would like to participate please fully read, sign, and return this form to the 
principal investigator of this study (Heath Burton). You will receive a copy of this form 
for your personal records. 
 
Will there be any compensation? 
 
You will not receive any type of payment participating in this study. 
 
What if you are injured because of the study?   
 
1. The University has no program or plan to provide treatment for research related 
injury or payment in the event of a medical problem. In the event of a research related 
injury, please contact the principal investigator. 
 
2. The University has no program or plan for continuing medical care and/or 
hospitalization for research-related injuries or for financial compensation. 
 
3. If injuries occur as a result of study activity, eligible University students may be 
treated at the usual level of care with the usual cost for services at the Student Health 
Center, but the University has no program or plans to provide payment in the event of 
a medical problem. 
 
How will your privacy and confidentiality be protected if you participate in this 
research study? 
 
Each subject will be assigned a unique Subject ID code. This informed consent form and 
the Health History Questionnaire are the only places where any personal identifying 
information will be recorded. These forms will be stored in a locked file cabinet. In all 
other cases, your data will only be identifiable by your unique code. Only the director of 
the laboratory (Dr. Coyle) will have access to a master list that will link your identity to 
your code. 
 
Because you will be participating in this study and may do so along with other subjects in 
a small group, we will ask that you do not disclose names of participants in your group or 




If it becomes necessary for the Institutional Review Board to review the study records, 
information that can be linked to you will be protected to the extent permitted by law. 
Your research records will not be released without your consent unless required by law or 
a court order. The data resulting from your participation may be made available to other 
researchers in the future for research purposes not detailed within this consent form. In 
these cases, the data will contain no identifying information that could associate it with 
you, or with your participation in any study. 
 
If you choose to participate in this study, you may be photographed or video recorded. 
Any photographs or video recordings will be stored securely and only the research team 
will have access to the recordings. Recordings will be kept for 3 years after the research 
experiment has been completed and then erased. 
 
Whom to contact with questions about the study?   
Prior, during or after your participation you can contact the researcher Heath Burton at 
(864)-940-4103 or send an email to heath.burton@utexas.edu for any questions or if you 
feel that you have been harmed. 
 
This study has been reviewed and approved by The University Institutional Review 
Board and the study number is 2016-12-0022. 
 
Whom to contact with questions concerning your rights as a research participant? 
 
For questions about your rights or any dissatisfaction with any part of this study, you can 
contact, anonymously if you wish, the Institutional Review Board by phone at (512) 471-




If you agree to participate please sign and return this form to a member of the research 
team. 
 
Signature   
You have been informed about this study’s purpose, procedures, possible benefits and 
risks, and you have received a copy of this form. You have been given the opportunity 
to ask questions before you sign, and you have been told that you can ask other 
questions at any time. You voluntarily agree to participate in this study.  By signing this 
form, you are not waiving any of your legal rights. 
 
 
Photography and video recording of your sessions is optional. However, if 
participants agree to be photographed or video recorded their images may also be 
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used for professional and educational presentations not related to this research 
study. 
 
______ I agree to be photographed and video recorded. 
 






_________________________________       _________________ 
 
Signature           Date 
 
As a representative of this study, I have explained the purpose, procedures, benefits, and 




Print Name of Person obtaining consent 
 
_________________________________       _________________ 
 





Appendix B: Health History Questionnaire 
Health History Questionnaire 
 
IRB #: 2016-12-0022                                          Subject ID: _________________ 
 
Please answer the following questions to the best of your knowledge. If you do not know the 
answer to a specific question, please place a question mark in one of the spaces. If a question 
asks for more information beyond “Yes” or “No,” please provide all knowledge to the best of 
your ability. 
 
                 Yes    No 
1. Have you ever been diagnosed by a doctor as having a heart condition?    ___     ___ 
a. If yes, have you ever been advised to only perform medically 
supervised activity?                ___     ___ 
2. Do you have or have you ever had chest pain brought on by physical  
activity?               ___     ___ 
3. Have you ever been prescribed medication for a heart condition?        ___     ___ 
a. If yes, what medication? 
_______________________________________________ 
4. Are there any conditions that you are currently aware of that would 
prevent you from engaging in physical activity?          ___     ___ 
5. Do you smoke or have you smoked within the last (6) months?        ___     ___ 
6. Have you had any family members with a history of heart conditions?      ___      ___ 
7. Have you ever experienced shortness of breath during or after physical 
activity?               ___     ___ 
8. Have you ever experienced heart palpitations or an abnormally high 
heart rate brought on by physical activity?           ___     ___ 
9. Has a doctor ever diagnosed you with a heart murmur?         ___     ___ 
10. Do you ever experience abnormal pain in your legs during physical 
activity that is relieved by rest?            ___     ___ 
11. Do you have any joint or bone issues that may be aggravated by 
any type of exercise testing?            ___     ___ 
12. Are you currently experiencing any joint or muscle problems?        ___     ___ 
a. If yes, please describe: 
________________________________________________ 
13. Do you or have you ever had asthma that could be aggravated by  
physical activity?               ___     ___ 
14. When was your last menstrual cycle? 
___________________________________________ 
15. Do you have or have you ever had: 
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a. Chronic, severe headaches             ___     ___ 
b. Head injury (i.e. concussion, etc.)            ___     ___ 
c. Epilepsy               ___     ___ 
d. Abdominal pain, hernia, GI bleeding           ___     ___ 
e. Kidney problems              ___     ___ 
f. Anemia               ___     ___ 
g. Hemophilia               ___     ___ 
h. Lung problems              ___     ___ 
16. Have you donated blood or lost a significant amount of blood within 
the past 2 weeks?               ___     ___ 
17. Are you currently or have you been pregnant within the last month?         ___     ___ 
18. Have you recently been ill?              ___     ___ 
a. If yes, please describe: 
______________________________________________________________ 
19. Have you been injured within the past month?           ___     ___ 
a. If yes, please describe: 
______________________________________________________________ 
20. Have you been injured within the past year (beyond #17) that still 
presents symptoms or issues?             ___     ___ 
21. Are you currently taking any prescribed, non-cardiac related medications? ___     ___ 
a. If yes, what medications? 
______________________________________________________________ 
22. Are you currently taking any over the counter medications?          ___      ___ 
a. If yes, what medications? 
______________________________________________________________ 
23. Do you currently train for exercise?             ___      ___ 
a. If yes, for how many years have you trained? 
______________________________________________________________ 
b. If yes, what type of training do you complete? 
______________________________________________________________
______________________________________________________________ 




Appendix C: Blood Analysis 
PLASMA GLUCOSE MEASUREMENTS 
Plasma glucose is measured by a spectrophotometric method using commercially 
available kits (Pointe Scientific, Inc. Canton, USA). The plasma samples are removed 
from freezer (-80°C) and thawed in an ice-water bath. 3 µL of plasma sample is added to 
300 µL of glucose reagent and then incubated at room temperature for 10 minutes, 5 
minutes of which are on an oscillating tray. Glucose is phosphorylated with ATP to 
produce glucose 6-phosphate (G-6-P) in the reaction catalyzed by hexokinase (HK). The 
glucose 6-phosphate is then oxidized with concomitant reduction of NAD to NADH in 
the reaction catalyzed by glucose 6-phosphate dehydrogenase (G6PDH). The absorbance 
of NADH formed will be measured at 340 nm using a microplate reader (Tecan Infinite 
200 PRO, Tecan Group Ltd., Männedorf, Switzerland). The concentration of NADH is 
directly proportional to the concentration of glucose in the sample. 
PLASMA TRIGLYCERIDE MEASUREMENTS 
Plasma triglyceride will be measured using a spectrophotometric method using a 
commercially available kit (Pointe Scientific, Inc., Canton, USA). When beginning 
analysis, plasma samples are removed from the freezer and thawed at room temperature 
and vortexed. 3 µL of plasma is then pipetted off and added to 300 µL of pre-warmed 
(37°C) triglyceride reagent. These samples are and incubated for 5-minutes on an 
oscillating tray. The plate is then moved to a warm (37°C) to finish incubating for 20-
minutes. The reagent used hydrolyzes triglycerides in the sample via lipase and produces 
glycerol and free fatty acids. Glycerol is then phosphorylated by ATP to glycerol 1-
phosphate and ADP through a reaction catalyzed by glycerol kinase (GK). The glycerol 
1-phosphate is then oxidized by glycerol phosphate oxidase (GPO) to yield hydrogen 
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peroxide. The condensation of hydrogen peroxide with 4-chlorophenol and 4-
aminophenazone (4-AA) in the presence of peroxidase (POD) produces a red colored 
quinonimine dye. The intensity of the colored complex formed is directly proportional to 
the triglycerides concentration of the sample. The plate is read at 500 nm using a 
microplate reader (Tecan Infinite 200 PRO, Tecan Group Ltd., Männedorf, Switzerland). 
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Appendix D: Raw Data 
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